169 related articles for article (PubMed ID: 33128015)
21. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment.
Allan RS; Zueva E; Cammas F; Schreiber HA; Masson V; Belz GT; Roche D; Maison C; Quivy JP; Almouzni G; Amigorena S
Nature; 2012 Jul; 487(7406):249-53. PubMed ID: 22763435
[TBL] [Abstract][Full Text] [Related]
22. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene.
Lin H; Shabbir A; Molnar M; Lee T
Biochem Biophys Res Commun; 2007 Mar; 355(1):111-6. PubMed ID: 17280643
[TBL] [Abstract][Full Text] [Related]
23. Pseudogenes: Four Decades of Discovery.
Salmena L
Methods Mol Biol; 2021; 2324():3-18. PubMed ID: 34165705
[TBL] [Abstract][Full Text] [Related]
24. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
[TBL] [Abstract][Full Text] [Related]
25. HPV16 activates the promoter of Oct4 gene by sequestering HDAC1 from repressor complex to target it to proteasomal degradation.
Liu D; Zhou P; Zhang L; Zheng Y; He F
Med Hypotheses; 2012 Oct; 79(4):531-4. PubMed ID: 22867868
[TBL] [Abstract][Full Text] [Related]
26. The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene.
Lister N; Shevchenko G; Walshe JL; Groen J; Johnsson P; Vidarsdóttir L; Grander D; Ataide SF; Morris KV
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9942-9947. PubMed ID: 28847966
[TBL] [Abstract][Full Text] [Related]
27. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.
Wang L; Guo ZY; Zhang R; Xin B; Chen R; Zhao J; Wang T; Wen WH; Jia LT; Yao LB; Yang AG
Carcinogenesis; 2013 Aug; 34(8):1773-81. PubMed ID: 23615404
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
29. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
30. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
Gu P; Le Menuet D; Chung AC; Cooney AJ
Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
[TBL] [Abstract][Full Text] [Related]
31. lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells.
Mirzadeh Azad F; Malakootian M; Mowla SJ
Sci Rep; 2019 Jun; 9(1):8370. PubMed ID: 31182783
[TBL] [Abstract][Full Text] [Related]
32. SUV39H1-Mediated
Zhang L; Tian S; Zhao M; Yang T; Quan S; Song L; Yang X
Anticancer Agents Med Chem; 2021; 21(6):756-765. PubMed ID: 32698743
[TBL] [Abstract][Full Text] [Related]
33. The lncRNA
Lo Piccolo L; Mochizuki H; Nagai Y
J Cell Sci; 2019 Oct; 132(20):. PubMed ID: 31519807
[TBL] [Abstract][Full Text] [Related]
34. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
[TBL] [Abstract][Full Text] [Related]
35. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
36. LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a.
Zhu H; Zheng T; Yu J; Zhou L; Wang L
Biomed Pharmacother; 2018 Sep; 105():789-797. PubMed ID: 29909347
[TBL] [Abstract][Full Text] [Related]
37. OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma.
Bai M; Yuan M; Liao H; Chen J; Xie B; Yan D; Xi X; Xu X; Zhang Z; Feng Y
Oncol Rep; 2015 Apr; 33(4):1745-52. PubMed ID: 25634023
[TBL] [Abstract][Full Text] [Related]
38. SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.
Kim G; Kim JY; Lim SC; Lee KY; Kim O; Choi HS
FASEB J; 2018 Oct; 32(10):5647-5660. PubMed ID: 29750576
[TBL] [Abstract][Full Text] [Related]
39. The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.
Yu J; Zhang J; Zhou L; Li H; Deng ZQ; Meng B
Med Sci Monit; 2019 Feb; 25():1204-1213. PubMed ID: 30762028
[TBL] [Abstract][Full Text] [Related]
40. miR-2682-3p antagonizes its host lncRNA-MIR137HG by interacting with the same target FUS to regulate the progression of gastric cancer.
Du Y; Chen Y; Wu T; Fan X; Lin W; Jiang Z
BMC Cancer; 2022 Jun; 22(1):689. PubMed ID: 35733138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
